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When antibody binds to target cell antigens alterations occur in the Fc portion 
of the immunoglobulin molecule which can lead to activation of various immuno- 
logical effector mechanisms, e.g.  the complement (C)  system or cytotoxic effec- 
tor cells.  The activation of such effector mechanisms can be used for assaying 
antibody activity. C-dependent antibody assays have been widely used but often 
suffer from  low  reproducibility and  may give  different results  with  different 
sources of C. 
Cell-dependent  antibody-mediated  cytotoxicity (1,  2)  has  proven  to  be  a 
powerful assay for antibody in  some  systems (3). However,  the  interaction of 
lymphoid cells with antibody-coated target cells does not always result in target 
cell  lysis.  For example,  human peripheral  blood  leukocytes lyse alloantibody- 
coated human lymphocytes with great sensitivity (4, 5). In contrast, mouse spleen 
cells,  which are a good source of effector cells I in some xenogeneic systems (6-9) 
do not lyse alloantibody-coated mouse lymphocytes (P.  Halloran, unpublished 
data; I. C. M. Maclennan and I. MacKenzie, personal communications). Reasons 
for these striking species differences are at present unknown, but these findings 
imply that the induction of target cell lysis in cell-dependent antibody-mediated 
systems cannot be generally used to detect antitarget cell antibody. 
In the present series we describe a  new widely applicable assay for antibody 
which is based on inhibition rather than induction of cell-dependent antibody- 
mediated cytotoxicity. The cytotoxicity test system consists of (a) normal mouse 
* This  work  was supported  by  the  Cancer  Research  Campaign,  the  National  Kidney Research 
Foundation, The Wellcome Trust, and by an Ontario Department of Health Fellowship. 
' The effector cells probably represent only a  small fraction of the total spleen cell population. For 
the nature of' the cells, see Discussion. 
1348  THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  •  VOLUME  140, 1974 PHIL  HALLORAN, VOLKER SCHIRRMACHER, HILLIARD FESTENSTEIN  1349 
spleen  cells  (effector  cells),  (b)  ~lCr-labeled  chicken  erythrocytes  (CRBC) ~ 
(target  cells),  and  (c)  minute  amounts  of rabbit  anti-CRBC  antibody  (RACA) 
(8).  In a preliminary communication (10)  we showed that anti-H-2 sera directed 
against  alloantigens  in  the  effector  cell  population  can  specifically  inhibit  the 
cytotoxicity in this test system. It will be shown in this series that a  variety of 
allogeneic and  xenogeneic antisera  capable  of reacting with  surface  antigens  in 
the effector cell population lead to inhibition of target cell lysis in the above sys- 
tem. This reaction forms the basis of the cytotoxicity inhibition assay (CIA) which 
will be presented as a  new antibody assay,  independent of C. The specificity and 
sensitivity  of the  CIA  will be  described  in  this  report.  The  advantages  of this 
assay  over conventional assays  and  some possible applications  of it will be  dis- 
cussed. 
Materials  and Methods 
Materials.  Culture  medium:  Eagles  MEM  (The  Wellcome  Research  Laboratories,  Kent,  Eng- 
land)  with  0.013 M  bicarbonate and  antibiotics (Gentamycin 5 ug/ml, cloxacillin  125 ~g/ml, and 
ampicillin  125  ~g/ml)  and  5%  fetal  calf serum  (Flow Laboratories,  Inc.,  Rockville,  Md.}. Culture 
tubes:  flat-bottomed 9 ×  44 mm polystyrene tubes  (The Metal Box Co., Surrey,  England).  Isotope: 
radioactive sodium chromate (~ ICr, 1 mCi/ml) (The Radiochemical Centre,  Amersham, England}. 
Animals.  Young  adult  male  and  female  mice  were  used.  Strains  CBA/H,  BALB/c,  DBA/2, 
C57B1/6,  C57B1/10ScSn  (abbreviation  "B10"),  B10.A, B10.D2, B10.BR, and  nude  (nu/nu)  mice 
were bred  in this  laboratory  or obtained from  the Laboratory  Animal Centre,  Carshalton,  Surrey, 
England. Strains B10.A(2R), B10.A(4R), B10A(5R), B10.HTT,  A.TH,  B10.D2(M504), and B10.AKM 
were bred in this center from breeding pairs obtained from Dr. Peter Demant, Institute of Experimen- 
tal Biology and Genetics,  Prague, Czechoslovakia; from Dr. Donald Shreffler, University of Michigan, 
Ann Arbor, Mich.;  and from Dr. H. 0. McDevitt and B. Deak, Stanford University, Stanford,  Calif. 
The  congenic  and  recombinant  strains  used  were  discovered  and  established  by  Snell,  Shreffler, 
Demant, Stimpfling, Gorer, Ivanyi, and Egorov. 
Antisera 
ANTI-~/-2 ALLOANTISERA.  Table I  contains  the details of the anti-H-2 sera  used.  Alloantisera  1-6 
were raised  by injecting at weekly intervals 107 spleen  cells (or P815 tumor cells for serum  5) intra- 
peritoneally into appropriate recipients.  Sera obtained after 2-3 mo were heat inactivated and stored 
at --20°C. Sera 7-13 were obtained from the Transplantation and Immunology Branch,  NIAID, NIH, 
Bethesda,  Md. Details of the raising and testing of these sera are contained in the NIH catalogue 3  and 
in its 1973 supplement. 
RABBIT ANTIMOUSE GAMMA  GLOBULIN  (R ANTI-MGG).  Rabbits were immunized at weekly intervals 
with a suspension of Proteus OX2 organisms which had been coated with mouse anti-Proteus  anti- 
bodies and carefully  washed. Anti-MGG antibodies were immunosorbent purified  using MGG-linked 
2Abbreviations  used  in  this paper:  CDL,  C-dependent lysis;  CIA, cytotoxicity inhibition assay; 
CRBC, chicken  erythrocytes; Ia antigens,  I-region-associated  antigens; NMG, normal mouse gamma 
globulin;  NRG, normal  rabbit  gamma  globulin;  RACA,  rabbit  anti-CRBC antibody;  R  anti-BA0, 
rabbit antimouse brain-associated-8;  R anti-MBLA, rabbit antimouse bone marrow-derived  lympho- 
cyte antigen; R anti-MGG, rabbit antimouse gamma globulin (from immune serum}. 
3  Snell,  G. D. 1968. Catalogue  of Mouse Alloantisera.  Transplantation Immunology  Branch  Publi- 
cation,  National Institute of Allergy and Infectious  Disease, National Institutes of Health,  Bethesda, 
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TABLE  I 
H-2 Antisera 
Serum  Anti-H-2 
No.  Recipient-donor strains  Recipient-donor genotypes 
designation  specificities 
1  "k anti-d"  CBA/H anti-BALB/c 
2  "d anti-k"  BALB/c anti-CBA/H 
3  "k × danti-b"  (CBA/H ×  BALB/c)F~ 
anti-C57BL/6 
4  "b anti-d"  C57BL/6 anti-BALB/c 
5  "k anti-P815Y"  CBA/H anti-P815Y 
6  "b anti-5R"  B10 anti-B10.A(5R) 
7  "D-4"  (B10.AKM  ×  129)F~ 
anti-BIO.A; 
8  "D-8"  (B10  ×  A.SW)F1 
anti-BIO.M; 
9  "D-23"  (B10  ×  LP.R  III)F, 
anti-B10.A(2R); 
10  "D-25"  (B10.D2  x  C3H.NB)F~ 
anti-B10 R.III; 
11  "D-31"  (B10 × A)F~ anti-B10.D2; 
12  "D-33"  (B10.D2  ×  A)F~ 
anti-B10.A(5R); 
13  "D-35"  B10.A (2R)  × A.CA)F1 
anti-B10.Y. 
H-2  ~ anti-H-2  d  multiple 
H-2  d anti-H-2  ~  multiple 
(H-2~/H-2  ~) anti-H-2  b  multiple 
H-2 b anti-H-2  ~  multiple 
H-2 k anti-H-2  ~  multiple 
H-2 b anti-H-2  ~5  multiple 
(H-2m/H-2 be) anti-H-2"  4 
(H-~/H-2  ~) anti-H-2 t  8, 9, 37 
(H-2b/H-2 r) anti-H-2  a2  23 
(H-2d/H-2 p) anti-H-2"  25,11,18,54 
(H-2b/H-2  ~) anti-H-2  ~  31,  34 
(H-2~/H-2  ") anti-H-2  ~5  33, 53, 54 
(H-21'~/H-U) anti-H-2  pa  35,34,41 
Sepharose 4B beads, which were prepared as described (11).  Absorbed antibodies were re-eluted by 
suspending the beads for  15 min at  37°C in 0.1  M  acetic acid,  pH 3.0.  The neutralized supernates 
had a  specific agglutination titer against MGG-coated sheep erythrocytes (SRBC) (12) of more than 
1:106. 
RABBIT ANTIMOUSE BRAIN-ASSOCIATED-~ (R  ANT1-BA~). Rabbits  were  immunized twice  with  mouse 
brain tissue emulsified in complete Freund's adjuvant (13). Antisera obtained 2  3 mo after immuniza- 
tion were inactivated tbr 30 min at 56°C before they were immunosorbent purified on mouse brain tis- 
sue. 5-ml antiserum was incubated for I h on ice with brain tissue from 15 BALB/c mice. Absorbed an- 
tibodies were re-eluted from the washed tissue by suspending it for  15  min at 37°C in 5  ml 0.1  M 
acetic  acid,  pH  3.0.  The  neutralized  supernate was further absorbed  with  MGG-Sepharose beads 
and with spleen cells from nude mice. It was then dialyzed against MEM. 
AKR/J ANT1-0C3H SERUM (ANTI-THY 1.2).  AKR/J anti-gC3H  serum pretested  for  specificity (14), 
was kindly donated by Dr. R. F. Kerbel, Queen's University, Kingston, Canada. 
RABBIT ANTIMOUSE BONE MARROW-DERIVED LYMPHOCYTE ANTIGEN (R  ANTI-MBLA).  Rabbits were  im- 
munized twice with spleen cells from adult thymectomized, 850 R  irradiated,  and bone marrow-re- 
constituted CBA/H mice (15).  The IgG fractions of antisera obtained after 2-3 mo were prepared by 
DEAE-cellulose  chromatography  (16).  They  were  absorbed  with  MGG-Sepharose  beads,  mouse 
brain tissue, and CBA/H thymus ceils. 
RACA.  Rabbits were immunized at weekly intervals with about 10 ~ washed fresh CRBC and bled 
after 5-6 wk. The heat-inactivated serum had a titer in the antibody-dependent cell-mediated cyto- 
toxicity assay (see below) of more than 1:106  . 
All xenogeneic antisera were found to be specific in conventional assays (C-dependent lysis [CDL], 
passive  hemagglutination, and  indirect  immunofluorescence) (Volker  Schirrmacher,  unpublished 
observations). 
C-Dependent  Microcytotoxicity.  Our  standard  method  fbr  CDL  was  a  microassay. The  test, 
which has been described previously (17) was performed in Microtest 3034  plates (Falcon Plastics, 
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cubated together at  room temperature,  for 30 min. Then 5 ttl of diluted rabbit  or guinea pig C  was 
added and the mixture was incubated at room temperature for 30 min. The results were read directly 
under  phase  contrast. 
Indirect  Immunofluorescence.  Cells were  labeled  with  rabbit  antisera  in  excess for  1 h  on  ice, 
washed, and then incubated again for  1 h  on ice with  1:4 diluted fluorescein-labeled goat antirabbit 
gamma globulin.  The  washed  cells were  observed  for  membrane fluorescence under a  fluorescence 
microscope using a  BG  12 (1 ram) filter. 
CIA.  To  culture  tubes were added:  1 or 2  ×  10' fresh CRBC  labeled  with  5~Cr  (18),  1-4  ×  108 
twice  washed  normal  mouse  spleen  cells,  and  RACA  to  give  a  final  concentration  of  1/25,000- 
1/100,000.  Inert  SRBC (107/ml) were added to reduce the spontaneous 5~Cr release (6). The serum to 
be tested was either added directly to the final incubation mixture or preincubated with "third-party" 
cells carrying the appropriate  determinants, which were then washed and added to the incubation 
mixture. 
The exact composition of the final incubation mixture and the duration of incubation varied accord- 
ing to the specific requirements: method A (to achieve a  convenient short-term assay), 3- to 4-h incu- 
bation;  effector  to  target  cell  ratio,  100-200:1;  RACA  concentration,  1/25,000;  and  method  B  (to 
achieve maximum sensitivity),  18-h incubation; effector to target  cell ratio,  50:1;  RACA concentra- 
tion,  1/100,000.  The basis for  the  selection  of these quantities  is given in the second paper  of this 
series. Where economy in consumption of antiserum was required,  a  final volume of 250 ttl was em- 
ployed; otherwise, the final volume was 1,000 td. 
Incubations were  performed  in a  desiccator at  37°C  in a  10%  O~ and 5%  COs atmosphere. After 
incubation (3, 4, or 18 h) the tubes were centrifuged and aliquots of the supernates were removed. The 
residual  incubation  mixtures and  the  supernatant  aliquots  were  counted  separately  in  a  Packard 
Autogamma well-type scintillation counter (Packard  Instrument Co.,Inc.,  Downers Grove, Ill.), and 
the  percent  ~xCr  release  was  calculated.  The  means and  standard  deviations  from  the  results  of 
triplicate  tubes were obtained,  and differences were assessed for significance by a  Student's t  test. 
The  inhibition  of 5~Cr  release  by the  test antiserum  was also tested against autologous,  parent,  or 
H-2 identical cells. Inhibition of cytotoxicity was considered specific only when greater than in these 
controls. 
The  CIA  results  could  be  expressed  in  several  ways:  (a)  percent  5~Cr  release;  (b)  reduction  in 
percent  51Cr  release,  i.e.  percent  51Cr  release  in  presence  of normal serum  minus percent  ~xCr re- 
lease in presence of antiserum (any nonspecific reduction observed with autologous cells was corrected 
for by subtraction);  and (c)  percent inhibition of cytotoxicity,  i.e.,  the reduction  in percent  5'Cr re- 
lease expressed as a  percentage. Examples of data expressed in each of these ways are included in the 
Results. 
Results 
Specificity of the CIA 
ANTI-H-2.  When  normal  mouse  spleen  cells  (effector  cells)  were  incu- 
bated  with  antibody-coated  and  5~Cr-labeled  CRBC  (target  cells),  the  spleen 
cells were induced to lyse the CRBC as demonstrated by the  s'Cr released into 
the supernate. The addition of anti-H-2 sera to the incubation mixture containing 
spleen  cells bearing the  appropriate 1"1-2 antigens  led to inhibition of the  cyto- 
toxicity. Fig.  1 illustrates the specificity of this reaction, comparing the effect of 
antiserum  with that of normal mouse serum.  Serum  "d  ×  k anti-b"  (anti 1t-2 ~) 
strongly inhibited the cytotoxicity of B10 (//-2  ~) spleen cells; yet it had no specific 
effect  on  the  cytotoxicity  of  BALB/c  (H-2  ~)  or  CBA/H  (H-2  k)  spleen  cells. 
Similarly, the sera "b anti-d" (anti-H-2  ~) and "k anti-d" (anti-H-2 ~) gave strong 
inhibitions of 5~Cr release by BALB/c spleen cells, and serum  "d anti-k"  (anti- 
1-1-2  ~)  inhibited  the  5'Cr  release by  CBA/H  spleen  cells.  As predictable  on the 1352  CYTOTOXICITY  INHIBITION ASSAY  SPECIFICITY  AND  SENSITIVITY 
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FIG.  1.  Specificity of the CIA. The cytotoxicity of' spleen cells from three different strains of 
mice (C57B1/10  Sc  Sn (H-2%, BALB/e (H-2"), and CBA/H (H-2  ~) was determined in absence 
or presence of either  normal mouse serum (control)  or various anti-H-2 sera.  For test condi- 
tions see method A. The final dilutions of the sera are indicated on the abscissa. ( *--* )  normal 
mouse  serum;  (O--C))  "k  x  d-anti  b"  (anti-H-2b);  (O--O)  "b  anti-d"  (anti-H-2a);  (A--A) 
"k  anti-d"  (anti-H-2e);  and  (A--A)  "d  anti-k"  (anti-H-2~). Background  slCr  release  with- 
out RACA was 2%. 
basis of public specificities in the H-2 chart (19), inhibition of cytotoxicity was 
observed with serum "b anti-d" tested against CBA/H and with the sera "k anti-d" 
and "d anti-k" tested against B10 spleen cells. None of the sera inhibited the cyto- 
toxicity of cells which were autologous, parent, or H-2 identical to the strain in 
which  the  antibody  was  raised.  Thus,  the  ability of anti-H-2  sera  to  inhibit 
cytotoxicity in our system was specific. The pattern of inhibition described above 
suggested that the activity of the sera was directed against "serologically-defined" 
private and public specificities of the H-2 complex. 
For more definitive elucidation of the regions in the H-2 complex controlling 
the  antigens  recognized  by  the  CIA,  we  investigated the  inhibitory effects of 
well-characterized NIH H-2 antisera 3 against cells from various inbred, congenic, 
and recombinant strains. Table II contains the results of these studies, comparing 
the antigens expected to be present on the cells (on the basis of their H-2 genotype) 
with the results obtained in the CIA. A complete correlation was found between 
the pattern of antigens expected and the pattern of inhibition observed. The sera 
used were directed against private specificities located in the H-2 K  region (H- 
2K.23,  H-2K.31,  and H-2K.33)  or  H-2  D  region (H-2D.4)  and against a  public 
specificity mapping  in  the  H-2  K  region (H-2K.8).  Our results therefore show 
that the CIA can detect private and public specificities of the H-2 K and H-2 D 
genes. 
Furthermore, other serological specificities located in the H-2 complex could 
be detected in the CIA as well. Between the H-2K and the H-2D loci,  there is a PHIL  HALLORAN,  VOLKER  SCHIRRMACHER,  HILLIARD  FESTENSTEIN 
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Results of Testing anti-H-2 Sera of Narrow Specificity in the CIA 
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Effector cells  H-2 type 
Predicted reactions$ 
Inhibition of cytotoxicity  § 
in presence of antiserum 
D-4  D-8  D-23  D-31  D-33  D-4  D-8  D-23  D-31  D-33 
%  %  %  %  % 
DBA/2  d  +  +  -  +  -  41"*  26**  0  51"**  0 
CBA/H  k  -  +  +  2  20**  33**  3  8 
B10  b  ....  +  10  10  15  10  85*** 
0  3  8  3  58*** 
B10.D2  d  +  +  +  -  64***  57***  0  71"**  7 
B10.D2(M504)  d  +  +  -  +  -  43***  53***  10  77***  13 
B10.HTT  t3  +  -  -  50***  3  9  6  NT 
B10.AKM  m  -  +  +  -  -  7  69***  66***  10  7 
8  32***  37***  5  NT 
B10.BR  k  -  +  +  -  -  12  47**  47**  6  0 
B10.A  a  +  +  +  -  -  55***  45***  65***  -5  -8 
B10.A(2R)  h2  -  +  +  -  -  4  38***  50***  0  -4 
B10.A (5R)  i5  +  -  -  -  +  32***  14  11  11  79*** 
(B10.A(2R) f  (h2 x  m)F,  -  +  +  -  -  7  64***  57***  14  NT 
B10.AKM)F~ 
(B10.A(2R)  x  (h2 f  d)F1  +  +  +  +  -  41"**  59***  41"**  63***  -7 
B10.D2)F1 
Predictions are based on the H-2 genotype of the mouse strain and on the specificities of the sera 
determined by complement-dependent lysis  2.  The  principal H-2 specificity is  indicated by the 
number of the antiserum, i.e., D-8 is directed at specificity H-2K.8. Other specificities are present 
in some of these sera  (see Table  I)  but  are not a  consideration in the strains selected here. Ia 
specificities may be present in some of these sera (e.g., D-33 contains anti Ia.9-see text) but cannot 
account for most of the reactions presented in this table. 
§ i.e.,  (%  "Cr release with normal serum  -  % ~Cr release with test serum)/(% s~Cr release with 
normal serum)  x  100; the numbers indicate arithmetic means; data based on five experiments, 
using the 4-h test (method A); cells from B10  and B10.AKM were tested twice and the data are 
presented to show the reproducibility. Asterisks indicate the level of significance in a Student's t 
test. *0.05  >  P  >  0.01;  **0.01  >  P  >  0.001;  and ***0.001  >  P. 
series of genes which control antigens  with a  restricted  tissue distribution.  These 
antigens  were  named  Ia  antigens  (I-region-associated  antigens)  because  the 
region  in  which  they  are  localized  is  called  the  immune  response  region  (20). 
The  results  presented  in  Table  III  indicate  that  these  specificities  can  be  de- 
tected  in  the  CIA.  The  sera  "b  anti-5R"  and  "D-33"  (both  anti-H-2 ~5)  were 
tested  against  strains  selected  to differ at various H-2 regions, particularly  I  and 
S.  "b  anti-5R"  specifically  inhibited  the  cytotoxicity  of  B10.A(5R),  B10.A, 
B10.A(2R),  and  B10.HTT  but  not  of  B10,  B10.A(4R),  and  A.TH.  Since 
B10.A(2R)  and  B10  A(4R)  are  identical  except  at  I-C  and  S,  the  inhibition  of 
the  cytotoxicity  of B10.A(2R)  is  explainable  only on  the basis of antigens  map- 
ping  in  these  regions. A  similar argument  holds true for the  difference observed 
between  B10.HTT  (positive)  and  A.TH  (negative).  Ia  specificities 6  and  7  (20) 
could account  for all  the  results  with  this serum,  since the  lack  of reaction  with 1354  CYTOTOXICITY  INHIBITION  ASSAY  SPECIFICITY  AND  SENSITIVITY 
A.TH  means that there  is  no  significant activity in  this serum against H-2D  ~ 
antigens (at the antiserum dilution tested  [1/150]).  Furthermore, the results ob- 
tained with serum D-33  suggest that this serum contains another anti-Ia speci- 
ficity.  The  serum  which  was  raised  against  differences  in  the  K  and  Ir-lA 
regions of B10.A(5R)  gave  positive reactions with A.TH and  B10.HTT.  These 
results  could  be  attributed  only to  Ia  specificity 9,  which maps  in  the Ir-lA 
region, but not to any H-2K  ~ antigens. Further investigations along these lines 
are in progress. 
AKR  ANTI-0C~H,  R  ANTI-BA~,  R  ANTI-MGG,  AND  R  ANTI-MBLA.  Cell surface anti- 
gens other than H-2 can also be detected in the CIA. The following allogeneic and 
xenogeneic  sera  were  tested:  (a)  AKR  anti-0C3H  (anti-Thy  1.2) (b)  R  anti- 
BA0,  (c)  R  anti-MGG,  and  (d)  R  anti-MBLA.  These  sera  were  specific  for 
either  mouse T  lymphocytes (sera a  and  b)  or for mouse B  lymphocytes (sera 
c and d)  when tested in CDL.  When  tested in the CIA, strong inhibition was 
observed  with  each  of these  sera  (for  titers  see  below).  In  order  to  test  the 
specificity of the inhibition of these antisera, we utilized the ability of antibody- 
coated  third-party  cells'  to  inhibit  cytotoxicity in  our  system (9). Cells  from 
CBA/H thymus (as a source of T  cells)  or from nude (nu/nu) mouse spleen cells 
(as a source of B  cells)  were incubated with the test sera, washed, and added to 
the  standard  cytotoxicity test  system.  Fig.  2  illustrates  the  results  obtained. 
While  ceils  pretreated  with  normal  rabbit  gamma  globulin  (NRG)  or  normal 
mouse gamma globulin (NMG) resulted in only slight changes in the cytotoxicity, 
the addition of antibody-coated third-party cells caused inhibition of varying de- 
grees.  The  specificity of these  reactions  is  represented  for each  serum  by the 
black and white columns (i.e.,  inhibition obtained with pretreated T  or B cells). 
The results generally corresponded with the results from conventional assays, 
such as CDL or indirect immunofluorescence (see lower part of the figure). Thus, 
thymus cells inhibited strongly only when pretreated with either of the anti-T-cell 
sera,  whereas  nude  spleen  cells  inhibited  strongly only when  pretreated  with 
either  of the anti-B-cell sera.  When the third-party cells were  complexed with 
anti  H-2  alloantiserum,  the  spleen  cells  showed  good  inhibition,  while  the 
addition of the  thymus cells  resulted  in a  surprisingly weak inhibitory effect. 
This finding may be  attributable  to differences in the amount of H-2 antigen 
expressed on the two cell populations (21). 
In  summary,  many antisera exert  specific  inhibitory effects when  tested  in 
the  CIA. The assay detected antibodies directed against (a)  public and private 
H-2D  and  H-2K  specificities  (b)  specificities  in  the  I  region  which  seem  to 
correspond with known Ia specificities, (c)  at least one non-H-2 alloantigen (i.e. 
Thy 1.2; antisera against other non-H-2 alloantigens have not been tested yet), 
and (d),  other cell surface antigens (e.g. immunoglobulin, MBLA). 
Sensitivity  of the  CIA 
Unlike most conventional assays, the CIA readily detects antibodies reacting 
with only a  minority of the cells in a heterogenous cell population. This is illus- 
* The  term  third-party  cells  does  not  imply  antigenic  differences  between  these  cells  and  the 
spleen (effector)  cells, but merely that they are exogenous to the latter. PHIL  HALLORAN,  VOLKER SCHIRRMACHER,  HILLIARD FESTENSTEIN  1355 
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trated in Table IV. In this experiment spleen cells from BALB/c mice were mixed 
with  spleen  cells  from  CBA/H  mice to  give effector cell  populations with the 
same total number of cells but with varying proportions of cells from each strain. 
Upon  addition of CBA/H anti-BALB/c serum,  inhibition of cytotoxicity could 
NRG  AKR  R anti-  R anti-  R anti-  anti-  NMG  Pretreated 
anti- 0 C3  H  BA8  MGG  MBLA  H-2 k  --  'inhibitor  cells' 
LO0-  "1100 ~  CBAthymus 
/  []  nu/nu spleen 
80 -  80 
60  60 
~a  40  40 
20  zo 
at 
Immunofluorescence 
-[:l:J  J÷l  I:J:J  -I:J.:J 
FIG.  2.  CIA with preformed antibody-coated  "third-party" cells ("inhibitor cells").  CBA/H 
thymus cells as source of  0-positive ceils or nu/nu spleen cells as source of B cells were prein- 
cubated for  1 h  on  ice  with the  indicated  immune or  control sera (purified gamma globulin 
fractions) and washed three times,  l0 s of these  cells were added to the standard cytotoxicity 
test  with antibody-coated  [51Cr]CRBC  as  target  cells  and  BALB/c  spleen  cells  as  effector 
cells (method A).  In absence of the inhibitor cells cytotoxicity,  expressed as percent  5'Cr re- 
lease,  was 62%;  background  5~Cr release  without RACA  was 2%.  The  lower part  illustrates 
the  results  of the  indirect  immunofluorescence test  performed with  the  same  cells using a 
fluoresceinated  goat  anti-rabbit  gammaglobulin antiserum.  ÷++,  intensive  stain  of all  or 
nearly all  cells,  +, faint stain of the majority of cells, and --, no specific stain. 
TABLE IV 
Detection  of Subpopulations  o[ Antigen-Bearing  Cells by the CIA 
Effector cells$  % Inhibition of cytotoxicity § in the presence of antiserum II 
BALB/c  CBA/H  "d anti-k .... k anti-d" 
%  % 
100  0  0 ~  8  94  ±  4*** 
95  5  50 ±  7**  94  ±  8*** 
90  10  56 ±  4***  100±  4*** 
50  50  78 ±  5***  94  ±  5*** 
10  90  83 i  3***  61  ±  5*** 
5  95  89 ±  5***  50 ±  8** 
0  100  88 ±  5***  13 ±  6 
$ Spleen  cells  from  BALB/c  or  CBA/H  mice  were  tested  either  separately  or  mixed  to  different 
proportions for cytotoxicity against antibody-coated ~lCr  labeled  CRBC  (method B). 
§ For expression of results and significant levels (asterisks) see footnote  § of Table II. The numbers 
indicate arithmetic means =F  standard deviation. 
II The sera were tested at a  final dilution of 1/500. PHIL  HALLORAN,  VOLKER  SCHIRRMACHER,  HILLIARD  FESTENSTEIN  1357 
be observed with as few as 5% of the total spleen cells being of BALB/c origin. 
Similarly, 5% of CBA/H cells in the effector cell mixture could be easily detected 
with a BALB/c anti-CBA/H serum. Thus, the CIA can easily detect antigens on 
subpopulations of cells. 
An important question relevant to the sensitivity of the CIA was whether the 
degree of cytotoxicity inhibition by antiserum reflected the total amount of anti- 
body capable of binding to cells in the incubation mixture. To investigate this 
point,  we  tested  whether there  was  an  additive  inhibitory effect in  the  CIA, 
when  equal  aliquots  of antiserum,  directed  either  against  one  or  against two 
different H-2  specificities expressed on the spleen cells,  were added to the  in- 
cubation mixture. Fig. 3 illustrates an experiment where antisera against speci- 
(a)  BIO.  [4-,31-] 
~10. A  [4% 31-]  ~ 
anti 4  (1/64) 
~anti 4  (1/128) 
t+anti 31{1/128) 
anti 31(~4) 
(c)  BIO. D2  [4*, 31+] 
÷ 
.J 
-I  0  +I  2  3  4  5  6  7  8  9  I0 
REDUCTION  IN  5~Cr RELEASE  (compared  to  normal  mouse  serum) 
FIG.  3.  Additive  effect  of antisera  against  different H-2 specificities  in  the  CIA.  The  cyto- 
toxicity  of spleen  cells  from  three  congenic  strains  of mice  (B10,  B10.A,  and  B10.D2)  was 
determined  in  the  presence  of  the  following  sera:  normal  mouse  serum  (control),  "D-4" 
(anti-H-2D.4),  "D-31" (anti-H-2K.31),  or  "D-4"  plus  "D-31".  The  sera were diluted  to give 
an  identical  mouse serum concentration (1/64) in all  incubation mixtures. For test conditions 
see  method  A.  The  results are  expressed as  percent  51Cr release  with normal serum minus 
percent  5~Cr release with test serum. The horizontal bars indicate  the  standard deviation of 
the mean. Background 5  ~Cr release in absence of RACA was 1%. 
ficities H-2D.4  and H-2K.31  were tested at identical total serum concentrations 
(1/64)  either separately or mixed 1:1, against effector cells from congenic strains 
negative for both antigens (B10), positive for one antigen (B10.A),  or positive for 
both  antigens (B10.D2).  The results show (i)  no significant inhibition of cyto- 
toxicity of B10 cells, (ii)  specific inhibition of cytotoxicity of B10.A and B10.D2 
cells,  and (iii)  additive effects when the amount of antibody was doubled (an- 
tibody  against  one  specificity:  compare  (b)  second  and  first  column;  anti- 
body against two specificities:  compare  the black  columns of b  and  c).  Thus, 
the degree of inhibition obtained with a  test serum in the CIA seems to reflect 
the number of antibody molecules binding to cells in the incubation mixture, re- 1358  CYTOTOXICITY  INHIBITION  ASSAY  SPECIFICITY  AND  SENSITIVITY 
gardless of the number of antibody specificities. In this respect, the CIA fulfills 
the prerequisites for a quantitative antibody assay. 
The sensitivity of the CIA was investigated for a variety of antisera and com- 
pared to the sensitivity of conventional assays (CDL, hemagglutination) (Table 
V).  The  inhibition  titers  represent  the  highest  antiserum  dilution  which  gave 
significant (P <  0.01)  inhibition  compared to  control sera  (or to antisera plus 
autologous cells in the case of anti-H-2 sera).  The data show that the titers for 
antioH-2 sera in the CIA were closely correlated (coefficient of correlation, r  = 
+0.96)  with  the  titers  in  CDL but  not with  the hemagglutination  titers ( r  = 
0.35). In every instance, the titers obtained in the CIA were higher (by factors 
ranging from 2 to 11) than the titers obtained in CDL. 
When  AKR  anti-0C3H,  R  anti-MBLA,  and  R  anti-MGG  were  tested  in 
CDL and in the CIA against C3H spleen cells, much higher titers were obtained 
in the CIA than in the C-dependent test. This difference, which was far greater 
than that obtained with anti-H-2 sera, may be due to the fact that the sera were 
reacting  only with  subpopulations  of the  spleen  cells.  Such  reactions  may be 
more difficult to detect in CDL than in the CIA. 
In summary, our investigations of the sensitivity of the CIA have shown that 
the  test  (a)  is  correlated  with  but  more  sensitive  than  C-dependent antibody 
assays;  (b)  reflects the number of antibody molecules binding to cell membrane 
antigens irrespective of whether they react with one or several different antigens; 
and  (c)  provides  a  powerful  tool  for detecting antibody on  subpopulations  of 
cells. 
Discussion 
Cell-dependent antibody-mediated cytotoxicity systems have been described in 
a number of instances, where antibody-coated target cells were incubated in vitro 
with nonimmune lymphoid cells. While there is general agreement that the effec- 
tor cells in these systems are  non-T cells which carry Fc receptors, their exact 
nature is still under discussion (references 22-24 and footnote 5). The antibody- 
mediating  cell-dependent cytotoxicity has  usually been found to be  of the  7S 
class (25, 26) and to be thymus dependent (27). 
Inhibition of cell-dependent antibody-mediated cytotoxicity  has been observed 
when either immune  complexes (9,  28)  or aggregated 7S  myeloma proteins (8) 
were added to the system. These reactions seemed to be due to immunoglobulin 
with altered Fc portions  competing with target cell-bound antibody for the  Fc 
receptor  of the  effector cell.  Inhibition  has  also  been  observed  with  antisera 
directed against cell surface antigens in the effector cell population, usually as an 
incidental observation, but has never been systematically investigated. In various 
systems,  antisera  against  immunoglobulin  (2,  6,  29),  T-cell  antigens  (30,  31) 
and HL-A antigens (5) were found to be inhibitory in the absence of C. We have 
~Pross, H.,  D.  E.  Tracey, H.  Wigzell, and  V.  Schirrmacher. 1974. Antibody-dependent  cell- 
mediated cytotoxicity  in the mouse. I. Surface  characteristics  of the effector  cell. Scand. J. lmmunol. 
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recently reported  that  anti-H-2  sera  also  contain  inhibitory activity which  is 
specific and absorbable (10). The inhibition observed with each of these antisera 
seems to be due to a mechanism similar to the one described above (see paper II). 
From  these  observations  we  concluded that  an  assay for antibody could be 
based  on the principle  of inhibition of cell-dependent antibody-mediated cyto- 
toxicity. Such an assay system, the CIA, has been described in the present report. 
The evidence presented indicates that it is capable of detecting antibody against 
a variety of cell surface antigens in the effector cell population: H-2 alloantigens 
mapping in the K, I, and D regions, non-H-2 alloantigens such as Thy. 1.2, and 
other antigens detectable by xenogeneic sera,  like MBLA and immunoglobulin. 
As in other systems (32), normal mouse serum had some nonspecific inhibitory 
activity, which was not completely removed by absorption with autologous cells. 
For  this  reason  normal  mouse  serum had  to be  included as a  control  in each 
experiment testing alloantisera. Whenever possible, antisera were tested against 
autologous or parent cells as an additional negative control. 
The antigens detected by the CIA may be identical to the antigens detected in 
CDL. Both, the specificities of anti-H-2 sera (Table II) and their titers (Table V) 
correlated  when  tested  in  CDL  and  CIA.  There  was,  however,  no  correlation 
between the  titers  obtained  in  CIA and  in hemagglutination tests (Table  IX). 
Reasons for this discrepancy are not clear. However, we have observed that (a) 
alloantibody-coated mouse  erythrocytes are  poorly inhibitory in  the  CIA even 
when using alloantisera with strong hemagglutinating activity, and  (b)  mouse 
erythrocytes have much less H-2 antigen than mouse lymphocytes when tested 
in  absorbtion  experiments.  Differences  in  antibody  class  and/or  in  antigen 
representation could account for the observed discrepancy. 
The  class of antibody detected in the  CIA is under study. From the known 
specificity of Fc receptors of cytotoxic effector cells for 7S  immunoglobulin (see 
above) it seems likely that the CIA measures only 7S, thymus-dependent antibody. 
The observed correlation of CDL and CIA in our studies may be due to the fact 
that we were testing hyperimmune sera only. In early immune sera which con- 
tain proportionately more  19S  antibody, CDL and  CIA may give different re- 
sults.  While CDL and hemagglutination assays measure both 19S and 7S  anti- 
body (with different sensitivity [33, 34]), an assay detecting only 7S  antibody 
would have the advantage of being more precise. 
The  CIA  seems  particularly  valuable  in  studying  membrane  antigens  ex- 
pressed  only on subpopulations of cells.  Even such small proportions as 5% of 
antigen-positive cells can readily be detected in the CIA (Table IV).  This may 
explain the high titers obtained in the CIA with antisera directed against either 
B  cells or T  cells (Table V).  Furthermore, the data in Table III suggest that Ia 
specificities,  which  are  preferentially expressed  on  B  cells  (35) can  be  easily 
studied with the  CIA.  The new assay therefore seems to provide a  convenient 
and objective assay for these potentially important specificities. 
In addition to its use  in identifying membrane antigens on mouse lymphoid 
cells,  the  CIA may be applicable  to the study of membrane antigens on other 
cells. We are studying a similar system with human effector cells and human allo- 
antisera and preliminary results suggest that some unexpected specificities may 
be  detectable. The fact that antigens on third-party cells  can be  tested in the PHIL  HALLORAN,  VOLKER  SCHIRRMACHER,  HILLIARD FESTENSTEIN  1361 
CIA by precoating them with specific antibody broadens the applicability of the 
system. For example,  cell surface antigens  on nonlymphoid cells (e.g., liver and 
nerve cells)  or tumor  cells might be investigated in this  way. The advantage  of 
such  an  approach  would  be  (a)  independence  of C,  (b)  no  requirement  for a 
purified test cell population, ahd (c) no requirement for radioactive labeling of the 
test cells. 
Summary 
Inhibition of cell-dependent antibody-mediated cytotoxicity has been investigated 
as a new assay for antibody against cell surface antigens. The cytotoxicity system 
consisted of effector cells (normal mouse spleen cells), target cells (~Cr-labeled 
chicken erythrocytes), and antitarget cell antibody. Addition of antibody against 
cell surface antigens in the effector cell population regularly inhibited the cyto- 
toxicity measured  in  this  system.  This  cytotoxicity inhibition  assay  (CIA)  de- 
tected antibody with a  variety of specificities:  anti-H-2,  anti-Thy 1.2,  anti-im- 
munoglobulin,  and  antimouse bone marrow-derived lymphocyte antigen.  When 
the inhibition by anti-H-2 sera was analyzed using effector cells from congenic 
mice, the activity was found to be directed against  specificities mapping in the 
H-2K,  H-2D,  and  I regions of the H-2 complex, correlating well with the speci- 
ficities characterized by complement-dependent assays. 
A  comparison between the sensitivity of the CIA and complement-dependent 
lysis revealed that the  CIA was 2-11 times more sensitive for anti-H-2 antisera 
and  20-780  times  more  sensitive for certain antisera  against  subpopulations  of 
the spleen cells (i.e., T  cells or B  cells). The CIA proved to be precise, sensitive, 
and  reliable.  It may become a  very useful antibody assay in various species in- 
cluding man. 
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